|Bid||20.46 x 1100|
|Ask||20.75 x 800|
|Day's Range||20.16 - 21.00|
|52 Week Range||20.16 - 27.02|
|Beta (5Y Monthly)||2.21|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||1.47 (7.08%)|
|Ex-Dividend Date||Feb 11, 2022|
|1y Target Est||N/A|
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces and territories of Canada.The Base Shelf Prospectus allows Innocan to qualify the distribution of up to ...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that an International Patent Application ("PCT") titled "Protein-bound Cannabinoid Formulations and Uses Thereof" was recently published and received the publication number WO 2022/070191 (the "Patent Application"), claiming priority from a US provisional application filed in October 2020.The Patent Applicati
Summit Hotel Properties (INN) delivered FFO and revenue surprises of 41.67% and 17.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?